Emerging business models for biotechnology firms and clusters: Policy responses in peripheral regions of the EU

Multinationals, Clusters and Innovation: Does Public Policy Matter?

Volumn , Issue , 2006, Pages 120-141

  Peters, Ewen ^a   Young, Stephen ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85009250541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1057/9780230624948     Document Type: Chapter

References (27)

1. Arthur D. Little, Biotechnologies: Parlons Vrai, Overview of Biotechnology Sector and Business Models (London, 2002).
2. Aydalot, P., Milieux Innovateurs en Europe (Paris: Gremi, 1986).
3. Barney, J.B., 'Firm resources and sustained competitive advantage', Journal of Management, 17 (1991) 99-120.
4. D'Cruz, J.R. and Rugman, A.M., Multinationals as Flagship Firms. Regional Business Networks (Oxford University Press, 2000).
5. DES, DTI, HM Treasury (Department of Education and Skills, Department of Trade and Industry, Her Majesty's Treasury), Science and Innovation: Working Towards a Ten-Year Investment Framework (London, March 2004).
6. DTI - Department of Trade and Industry (UK), Improving National Health, Increasing National Wealth, Bioscience Innovation and Growth Team (London: DTI, 2003).
7. The Economist Group, 'Drugs Ex Machina', The Economist Technology Quarterly, 22 September (2001) 36-8.
8. Enright, M.J., 'Regional clusters and multinational enterprises', International Studies of Management and Organization, 30(2) (2000) 114-38.
9. Ernst and Young, Integration, European Lifesciences Report 2001 (London, 2001).
10. European Commission, Lifesciences and Biotechnology: A Strategy for Europe (Brussels, 2002).
11. Fisherman, J.M., Biostrategy Seminar: Biotechnology Business Models (MIT 14 November, 2001).
12. Harvard Biotechnology Group, Five Broad Business Models for Biotechnology (McKinsey and Company, 2002).
13. ING, Biotech Valuation (December 2004).
14. Inkpen, A.C., 'Strategic alliances', in Rugman, A.M. and Brewer, T.L. (eds), The Oxford Handbook of International Business (Oxford University Press, 2001), pp. 402-27.
15. Inter-Departmental Committee on Science and Technology, Building Ireland's Knowledge Economy: The Irish Action Plan for Promoting Investment in R&D (Dublin, July 2004).
16. InterTrade Ireland, Mapping the Bio-Island (Dublin, 2003).
17. Irish Minister for Trade and Commerce as reported by Finfacts Ireland Business News (June, 2005) _www.finfacts.com_.
18. The Life Sciences Industry Advisory Group for Scotland, Scottish Lifescience Strategy: Achieving Critical Mass for Sustainable Growth - 2020 Vision (Glasgow, 2005).
19. Lim, L., 'Bio-business models', Cambridge Manufacturing Review, Winter (2003).
20. Maillat, D., 'Territorial dynamics, innovative milieu and regional policy', Entrepreneurship and Regional Development, 7 (1995) 157-65.
21. Malmberg, A., Sölvell, Ö. and Zander, I., 'Spatial clustering, local accumulation of knowledge and firm competitiveness', Geografiska Annaler, 78(2) (1996) 85-97.
22. Martin, P., The National Report of Ireland in Inventory of Public Biotechnology R&D Progress in Europe, Vol. 2 (Brussels: Office for Official Publications of the European Commission, 1999).
23. Pammolli, F. and Riccaboni, M., 'Geographical clusters in the biotechnology industry', Working Paper EPRIS Project (2001).
24. Penrose, E.T., The Theory of the Growth of the Firm (Oxford: Basil Blackwell, 1959).
25. Peters, E. and Hood, N. (2000), 'Implementing the cluster approach: Some lessons from the Scottish experience', International Studies of Management and Organization, 30(2) (2000) 68-92.
26. Peters, E. and Hood, N., 'Scotland's biotechnology cluster: Strategic issues and responses', in Hood, N., Peat, J., Peters, E. and Young, S. (eds), Scotland in a Global Economy: The 2020 Vision (London: Palgrave Macmillan, 2002), pp. 91-111.
27. Scottish Enterprise Web Site _www.scottish-enterprise.com_ (2005).